TP53 and hepatocellular carcinoma: MAP3K11, which is a MAP3K, is an upstream activator of JNKs, which in turn activate the downstream proteins c-Jun, p53, and the Bcl-2 family and ultimately result in phenotypic changes in HCC cells.